Table 5 Risk factors for cannulation failure
Univariate analysis | Multivariable analysis | |||
|---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | |
Papilla | ||||
1 | ref. | ref. | ||
2 | 7.91 (1.25–50.12) | 0.028* | 7.18 (1.05–49.19) | 0.045* |
3 | 7.25 (1.46–36.04) | 0.015* | 7.44 (1.45–38.28) | 0.016* |
4 | 3.87 (0.73–20.44) | 0.111 | 3.19 (0.58–17.43) | 0.181 |
PAD | ||||
0 | ref. | |||
2 | 0.74 (0.16–3.42) | 0.695 | ||
3 | 0.28 (0.06–1.27) | 0.099 | ||
Indication | ||||
Stone | ref. | ref. | ||
Cancer | 3.25 (1.10–9.64) | 0.033* | 4.45 (1.35–14.66) | 0.014* |
Other | 1.59 (0.33–7.72) | 0.567 | 2.60 (0.47–14.23) | 0.271 |
Diabetes | 0.35 (0.08–1.57) | 0.172 | ||
Hypertension | 0.83 (0.31–2.25) | 0.715 | ||
CVA | 3.39 (0.88–13.01) | 0.075 | ||
CRI | 0.56 (0.07–4.39) | 0.581 | ||
COPD | 4.99 (0.95–26.13) | 0.057 | ||
CAD | 0.93 (0.12–7.41) | 0.943 | ||
Cirrhosis | 0.00 (0.00- | 0.999 | ||
Age | 1.05 (1.01–1.09) | 0.010* | 1.06 (1.01–1.11) | 0.010* |
Gender-Male | 0.79 (0.30–2.12) | 0.647 | ||
Platelet | 1.00 (0.99–1.00) | 0.297 | ||
PT | 1.29 (1.00–1.66) | 0.054 | ||
APTT | 1.07 (0.99–1.16) | 0.083 | ||
AST | 1.00 (1.00–1.00) | 0.429 | ||
ALT | 1.00 (1.00–1.00) | 0.346 | ||
Bilirubin | 1.03 (0.95–1.12) | 0.469 | ||
Creatinine | 1.06 (0.59–1.89) | 0.851 | ||